Efficacy and safety of rituximab biosimilar in refractory lupus - a podcast by BMJ Group

Duane Peters from the Lupus Foundation of America interviews Dr Pintip Ngamjanyaporn and Dr Nantakarn Pongtarakulpanit from Mahidol University in Bangkok, Thailand, about their study on the short term efficacy and safety of rituximab biosimilar in refractory lupus.

Access the paper here: https://lupus.bmj.com/content/7/1/e000442

Further episodes of Lupus Science and Medicine podcast

Further podcasts by BMJ Group

Website of BMJ Group